COVID-19 Impact Analysis

• COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020. 
• Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing a shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness significant growth in the future, owing to the demand for vaccines and treatment drugs for COVID-19. 
• However, with COVID-19, the supply chain of the raw materials required to manufacture drugs for optic nerve disorders treatment has been disrupted in many countries. In addition, the market growth of pharmaceuticals is declining as the manufacturers of drugs have slowed down their production due to the pandemic. This, in turn, is expected to have a significant impact on the optic nerve disorders treatment market. 

Top Impacting Factors
The growth of the optic nerve disorders treatment market is attributed to the global rise in the number of cases of glaucoma. Glaucoma is caused by an increase in fluid pressure in the eyes. 
In addition, increase in the aging population across the world contributes to the growth of the optic nerve disorders treatment market. This is attributed to the fact that aged individuals are more prone to develop eye problems and optic nerve disorders.
One of the major causes of optic nerve disorders is when a patient has a traumatic head injury. Such injuries often happen during road accidents, which are on rise with a rise in population. This factor further propels the optic nerve disorders treatment market.
However, high cost associated with optic nerve disorders treatment and risks associated with various treatment methods are the factors that impede the growth of the market.
Key Market Trends

• In 2018, the pharmacological treatment segment dominated the global optic nerve disorders treatment. This segment involves the use of drugs such as corticosteroids, beta-blockers, beta interferons, and prostaglandins, which help to control the symptoms of various optic nerve disorders.
• The glaucoma segment holds a major share of the optic nerve disorders treatment market, owing to rise in prevalence of this condition in the global population and the launch of various effective combination therapies and products that help control it.
• North America and Europe are anticipated to hold a major share of the market during the forecast period, owing to increase in healthcare spending by the governments of nations in these regions and rise in awareness about optic nerve disorders.
• Asia-Pacific is expected to show lucrative growth in optic nerve disorders treatment due to the emergence of various market players in the region along with the slowly improving healthcare infrastructure in nations such as China and India. 

Key Segments Covered

Key Benefits of the Report

• This study presents the analytical depiction of the optic nerve disorders treatment industry along with the current trends and future estimations to determine the imminent investment pockets.
• The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the optic nerve disorders treatment market share.
• The current market is quantitatively analyzed from 2020 to 2030 to highlight the optic nerve disorders treatment market growth scenario.
• Porter’s five forces analysis illustrates the potency of buyers & suppliers in the optic nerve disorders treatment market. 
• The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.

Questions Answered in the Optic Nerve Disorders Treatment Report

• Which are the leading players active in the optic nerve disorders treatment market?
• How is each segment of the market expected to grow during the forecast period?
• What are the adoption trends for optic nerve disorders treatment in emerging economies and established economies across the world?
• What are the current trends that will influence the market in the next few years?
• What are the driving factors, restraints, and opportunities of the optic nerve disorders treatment market?
• What future projections would help in taking further strategic steps in the market?
• What are the impacts of COVID-19 on the industry?
• What are optic nerve disorders?
• What are the current and predicted trends of the market?